OPN binding to CD44 or integrins has been known to up-regulate the expression or activation of various downstream molecules such as MMP-2, MMP-9, cyclooxygenase-2, and vascular endothelial growth factor, which are essential for determining the oncogenic potential of various cancers [49–51]. Here, MMP9 is linked to cancer.